Organization · Private Equity
Xeraya Capital
Xeraya Capital is a private equity and venture capital firm based in Malaysia, focusing on investments in the life sciences sector. The firm aims to enhance human well-being and sustainability through its portfolio companies.
Overview
What Xeraya Capital does
What Xeraya Capital is
Xeraya Capital is a private equity and venture capital firm based in Malaysia, focusing on investments in the life sciences sector. The firm aims to enhance human well-being and sustainability through its portfolio companies.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Private Equity
- Structured capabilities
- Funder
- Last reviewed
- March 3, 2026
Official channels
Find Xeraya Capital elsewhere
Open the official website or a supported primary organization account.
Capability profile
Xeraya Capital as a funder
Investment thesis
Xeraya Capital invests in the life sciences sector with a focus on medical technologies, pharmaceutical biotech, and biorenewables. The firm emphasizes driving local value and sustainability through its investments.
Focus narrative
Xeraya Capital invests globally in the life sciences sector, emphasizing local value. Their focus includes medical technologies, pharmaceutical biotech, and biorenewables and agritech, employing a long-term investment strategy and collaborating with investee companies.
Focus and fit
- Regions
- Asia · Global
Availability
- Currently deploying
- Not published
Portfolio and track record
- Recorded notable exits
- Mirxes International Holdings Limited
Portfolio context
Xeraya Capital manages a diverse portfolio in medical technologies, pharmaceutical biotech, and biorenewables and agritech. Notable companies include Mirxes International Holdings Limited, which achieved a market cap exceeding USD 1 billion on its first trading day, Aria CV, which successfully implanted a second-generation pulmonary hypertension system, and Allecra Therapeutics, which received FDA approval for a urinary tract infection treatment.
Common questions
What to know about Xeraya Capital
Upseed classifies Xeraya Capital under the Private Equity organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 3, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.